AI assistant
Sending…
RELMADA THERAPEUTICS, INC. — Director's Dealing 2015
Dec 17, 2015
34465_dirs_2015-12-17_5495290e-8c36-4aeb-8af0-ce42c6b6ab73.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2015-12-16
Reporting Person: Agharkar Shreeram (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-16 | Common stock | P | 1000 | $3.45 | Acquired | 5259 | Direct |
| 2015-12-16 | Common stock | P | 100 | $3.25 | Acquired | 5359 | Direct |
More from RELMADA THERAPEUTICS, INC.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Capital/Financing Update
2026
Apr 9
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 12
Capital/Financing Update
2026
Jan 30
Director's Dealing
2025
Dec 16